Clinical trial
Canadian Fabry Disease Initiative National Registry: Outcomes of Rare Disease Therapeutics and Cardiovascular Risk Factor Modification
NCT00455104 is registered in ClinicalTrials.gov with Canadian Fabry Research Consortium as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Canadian Fabry Disease Initiative National Registry: Outcomes of Rare Disease Therapeutics and Cardiovascular Risk Factor Modification
- Lead sponsor
- Canadian Fabry Research Consortium
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- January 31, 2007
- Completion date
- October 31, 2029
- Enrollment
- 600 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.